Investment Summary

Illumina Invests In Nusantics

On September 14, 2022, Illumina invested in life science company Nusantics

Investment Highlights
  • This is Illumina’s 17th transaction in the Life Science sector.
  • This is Illumina’s 1st transaction in Indonesia.

Investment Summary

Date 2022-09-14
Target Nusantics
Sector Life Science
Investor(s) Illumina
Deal Type Stake Purchase

Target

Nusantics

Jakarta, Indonesia
Nusantics is a precision genomics company that develops and commercializes microbiome-related diagnostic tools tailored for the highly diverse Indonesian and Asian populations. Nusantics is based in Jakarta, Indonesia.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Illumina

San Diego, California, United States

Category Company
Founded 1998
Sector Life Science
Employees10,590
Revenue 4.4B USD (2024)
DESCRIPTION
Entrance to Illumina's corporate headquarters in San Diego, California.
Entrance to Illumina's corporate headquarters in San Diego, California.

Illumina is a developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. Illumina provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. Illumina was formed in 1998 and is based in San Diego, California.


DEAL STATS #
Overall 28 of 30
Sector: Life Science M&A 17 of 19
Type: Stake Purchase M&A Deals 13 of 13
Country: Indonesia M&A 1 of 1
Year: 2022 M&A 13 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-14 Dama Health

London, United Kingdom

Dama Health is a women's health company that offers precision screening to identify the most suitable contraception type and formulation, empowering women, people assigned to females at birth, and clinicians to make personalized reproductive health decisions. Dama Health is based in London, United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-09 Verogen

San Diego, California, United States

Verogen is a developer, manufacturer, and sells forensic genomics products and services, including for next-generation sequencing. Verogen was formed in 2017 and is based in San Diego, California.

Sell $150M